Clincosm LogoSign in Get a demo

Coronary Disease

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

International Post-PCI FFR Extended Registry

Completed
  • Coronary Disease
  • Percutaneous coronary intervention
  • Seoul, Korea, Republic of
    Bon-Kwon Koo
Jan 28, 2023

IRIS- DESyne X2 in the IRIS-DES Registry

Recruiting
  • Coronary Stenosis
  • +2 more
  • DESyne X2
  • Incheon, Korea, Republic of
  • +5 more
Dec 11, 2022

XIENCE Sierra in Routine Clinical Practice

Recruiting
  • Coronary Artery Disease
  • Coronary Disease
  • Xience Sierra stent
  • Busan, Korea, Republic of
  • +10 more
Dec 11, 2022

Bioresorbable Vascular Scaffold in Routine Clinical Practice

Active, not recruiting
  • Arterial Occlusive Diseases
  • +3 more
  • Bioresorbable Vascular Scaffold
  • Seoul, Songpa-gu, Korea, Republic of
  • +13 more
Dec 11, 2022

Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases Trial in Seoul (Synergy XD stent or Synergy Megatron™ Stent)

Not yet recruiting
  • Coronary Artery Disease
  • +4 more
  • Synergy XD stent or Synergy Megatron™ Stent
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 13, 2022

Coronary Disease, Coronary Stenoses Trial in Korea, Republic of (quantitative coronary angiography guided coronary intervention

Active, not recruiting
  • Coronary Disease
  • Coronary Stenoses
  • quantitative coronary angiography guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent
  • intravascular ultrasound guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent
  • Anam, Korea, Republic of
  • +8 more
Mar 1, 2022

Coronary Disease, Coronary Stenosis Trial in Worldwide (FFR guided PCI, CABG, Resolute Integrity Stent)

Active, not recruiting
Has Results
  • Coronary Disease
  • Coronary Stenosis
  • FFR guided PCI
  • +3 more
  • Palo Alto, California
  • +45 more
Dec 21, 2021

Development of Collateral Circulation for Coronary or Peripheral

Recruiting
  • Coronary Disease
  • +2 more
  • Blood samples
  • Seoul, Korea, Republic of
    Asan Medical Center
Sep 12, 2021

IRIS-PREMIER REGISTRY

Completed
  • Coronary Artery Disease
  • +3 more
  • Promus PREMIER
  • Anyang, Korea, Republic of
  • +24 more
Sep 6, 2021

Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold

Withdrawn
  • Coronary Disease
  • Computed tomographic scan
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 19, 2021

After Revascularization With Stent

Recruiting
  • Coronary Disease
  • Percutaneous coronary intervention
  • Seoul, Select, Korea, Republic of
    Seoul National University Hospital
Feb 23, 2021

Diabetes, Coronary Disease Trial in Seoul (Empagliflozin, Sitagliptin)

Completed
  • Diabetes Mellitus
  • Coronary Disease
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 5, 2019

Coronary Disease Trial in Korea, Republic of

Completed
  • Coronary Disease
    • Goyang, Gyeonggi, Korea, Republic of
    • +3 more
    Mar 2, 2019

    IRIS-Firehawk® Cohort in the IRIS-DES Registry

    Withdrawn
    • Coronary Stenosis
    • Coronary Disease
    • Firehawk
    • Seoul, Korea, Republic of
      Asan Medical Center
    Mar 7, 2018

    Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin System Trial in Seoul (6-month treatment)

    Completed
    • Inflammation Plaque, Atherosclerotic
    • +2 more
    • 6-month treatment
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 4, 2018

    Coronary Artery Disease, Coronary Disease, Cardiovascular Diseases Trial in Seoul (Rosuvastatin 5mg, Rosuvastatin 20mg)

    Unknown status
    • Coronary Artery Disease
    • +2 more
    • Rosuvastatin 5mg
    • Rosuvastatin 20mg
    • Seoul, Korea, Republic of
      Korea University Anam Hospital
    Aug 4, 2016

    VH-IVUS Plaque Composition Analysis By Fractional Flow Reserve

    Completed
    • Coronary Disease
      • Goyang, Gyeonggido, Korea, Republic of
      • +3 more
      Mar 23, 2015

      Coronary Disease Trial in Worldwide (Otamixaban (XRP0673), unfractionated heparin, eptifibatide)

      Completed
      • Coronary Disease
      • Otamixaban (XRP0673)
      • +2 more
      • Bridgewater, New Jersey
      • +35 more
      Nov 17, 2014

      Coronary Disease Trial in Worldwide (, dabigatran etexilate)

      Completed
      Has Results
      • Coronary Disease
      • placebo
      • dabigatran etexilate
      • Clearwater, Florida
      • +166 more
      Feb 10, 2014